SCHEMBL2858902

SCHEMBL2858902

COc1cc2c(cc1N)c(-c1cccc(F)c1)nn2C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.38
FYN P06241 4/20 0.36
KDM4E B2RXH2 4/20 0.36
KMT2A Q03164 4/20 0.36
MAPT P10636 4/20 0.36
MEN1 O00255 3/20 0.36
ALDH1A1 P00352 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
LMNA P02545 3/20 0.35
NTSR1 P30989 3/20 0.35
RORB Q92753 1/20 0.35
POLB P06746 1/20 0.35
HTT P42858 1/20 0.35
ADORA2B P29275 1/20 0.34
ADORA1 P30542 1/20 0.34
PDGFRB P09619 1/20 0.34
PDGFRA P16234 1/20 0.34
DPP4 P27487 1/20 0.34
GPR55 Q9Y2T6 2/20 0.34
F2RL3 Q96RI0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2864250 0.88 KDM4E (0.38) ADORA2AFYNKDM4EKMT2AMAPT
SCHEMBL2872658 0.86 ADORA2A (0.41) ADORA2AKDM4EALDH1A1NPSR1LMNA
SCHEMBL27536115 0.82 ALDH1A1 (0.41) KDM4EALDH1A1NPSR1LMNAPOLB
SCHEMBL2860001 0.80 ADORA2A (0.42) ADORA2AKDM4EALDH1A1NPSR1LMNA
SCHEMBL2861498 0.79 FYN (0.36) ADORA2AFYNADORA2BADORA1DPP4
SCHEMBL2857932 0.76 PTGER1 (0.41) KMT2AMAPTMEN1ALDH1A1POLB
SCHEMBL2867613 0.75 ADORA2A (0.39) ADORA2AKDM4EALDH1A1HTTADORA2B
SCHEMBL2870394 0.74 PTGER1 (0.43) ADORA2AKDM4EALDH1A1NPSR1LMNA
SCHEMBL4139399 0.73 CSNK2A2 (0.41) ADORA2AFYNKDM4EALDH1A1NPSR1
SCHEMBL4136387 0.73 CSNK2A2 (0.41) ADORA2AFYNKDM4EALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 ADORA2A 3048/4885FYN 235/4885KDM4E 2531/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 ADORA2A 4348/4885FYN 353/4885KDM4E 2430/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 ADORA2A 3048/4885FYN 235/4885KDM4E 2531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.